Global Bacterial Vaccines Market Overview:
Global Bacterial Vaccines Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2025 as the base year.
Global Bacterial Vaccines Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Bacterial Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Bacterial Vaccines Market:
The Bacterial Vaccines Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Bacterial Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Bacterial Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Bacterial Vaccines market has been segmented into:
Pertussis (Whooping Cough
By Application, Bacterial Vaccines market has been segmented into:
TB
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Bacterial Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Bacterial Vaccines market.
Top Key Players Covered in Bacterial Vaccines market are:
GlaxoSmithKline plc
Pfizer Inc.
Merck & Co. Inc.
Sanofi Pasteur SA
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Bharat Biotech International Limited
Biological E. Limited
Astellas Pharma Inc.
Seqirus (CSL Limited)
AstraZeneca
Novavax Inc.
Bavarian Nordic
Emergent BioSolutions Inc.
Valneva SE
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Immunomic Therapeutics
Inc.
Moderna
Inc.
Clover Biopharmaceuticals
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Bacterial Vaccines Market by Type
4.1 Bacterial Vaccines Market Snapshot and Growth Engine
4.2 Bacterial Vaccines Market Overview
4.3 Pertussis (Whooping Cough
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Pertussis (Whooping Cough: Geographic Segmentation Analysis
Chapter 5: Bacterial Vaccines Market by Application
5.1 Bacterial Vaccines Market Snapshot and Growth Engine
5.2 Bacterial Vaccines Market Overview
5.3 TB
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 TB: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Bacterial Vaccines Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GLAXOSMITHKLINE PLC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 PFIZER INC.
6.4 MERCK & CO. INC.
6.5 SANOFI PASTEUR SA
6.6 JOHNSON & JOHNSON
6.7 SERUM INSTITUTE OF INDIA PVT. LTD.
6.8 BHARAT BIOTECH INTERNATIONAL LIMITED
6.9 BIOLOGICAL E. LIMITED
6.10 ASTELLAS PHARMA INC.
6.11 SEQIRUS (CSL LIMITED)
6.12 ASTRAZENECA
6.13 NOVAVAX INC.
6.14 BAVARIAN NORDIC
6.15 EMERGENT BIOSOLUTIONS INC.
6.16 VALNEVA SE
6.17 TAKEDA PHARMACEUTICAL COMPANY LIMITED
6.18 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
6.19 IMMUNOMIC THERAPEUTICS
6.20 INC.
6.21 MODERNA
6.22 INC.
6.23 AND CLOVER BIOPHARMACEUTICALS
Chapter 7: Global Bacterial Vaccines Market By Region
7.1 Overview
7.2. North America Bacterial Vaccines Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Pertussis (Whooping Cough
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 TB
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Bacterial Vaccines Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Pertussis (Whooping Cough
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 TB
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Bacterial Vaccines Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Pertussis (Whooping Cough
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 TB
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Bacterial Vaccines Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Pertussis (Whooping Cough
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 TB
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Bacterial Vaccines Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Pertussis (Whooping Cough
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 TB
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Bacterial Vaccines Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Pertussis (Whooping Cough
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 TB
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Bacterial Vaccines Scope:
|
Report Data
|
Bacterial Vaccines Market
|
|
Bacterial Vaccines Market Size in 2025
|
USD XX million
|
|
Bacterial Vaccines CAGR 2025 - 2032
|
XX%
|
|
Bacterial Vaccines Base Year
|
2024
|
|
Bacterial Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GlaxoSmithKline plc, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA, Johnson & Johnson, Serum Institute of India Pvt. Ltd., Bharat Biotech International Limited, Biological E. Limited, Astellas Pharma Inc., Seqirus (CSL Limited), AstraZeneca, Novavax Inc., Bavarian Nordic, Emergent BioSolutions Inc., Valneva SE, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Immunomic Therapeutics, Inc., Moderna, Inc., and Clover Biopharmaceuticals.
|
|
Key Segments
|
By Type
Pertussis (Whooping Cough
By Applications
TB
|
